Literature DB >> 25208727

Acute effects of MDMA on autonomic cardiac activity and their relation to subjective prosocial and stimulant effects.

Christine M Clark1, Charles G Frye, Margaret C Wardle, Greg J Norman, Harriet de Wit.   

Abstract

MDMA is a stimulant with unique "prosocial" effects, the physiological and pharmacological mechanisms of which are unknown. Here, we examine the relationship of measures of parasympathetic and sympathetic nervous system activity to the prosocial effects of MDMA. Parasympathetic activity was measured using respiratory sinus arrhythmia (RSA) and sympathetic activity using pre-ejection period (PEP). Over three sessions, 33 healthy volunteers received placebo, 0.75 mg/kg, and 1.5 mg/kg MDMA under counterbalanced, double-blind conditions, while we measured subjective feelings, RSA, and PEP. RSA and PEP data were available for 26 and 21 participants, respectively. MDMA increased prosocial and stimulated feelings, decreased RSA, and decreased PEP. At 1.5 mg/kg, subjective prosocial effects correlated with stimulated feelings and PEP, but not RSA. This suggests sympathetic, rather than parasympathetic, effects relate to the prosocial effects of MDMA.
© 2014 Society for Psychophysiological Research.

Entities:  

Keywords:  Ecstasy; MDMA; Pre-ejection period; Respiratory sinus arrhythmia; Social emotion

Mesh:

Substances:

Year:  2014        PMID: 25208727      PMCID: PMC4634859          DOI: 10.1111/psyp.12327

Source DB:  PubMed          Journal:  Psychophysiology        ISSN: 0048-5772            Impact factor:   4.016


  39 in total

Review 1.  Psychosocial treatment of posttraumatic stress disorder.

Authors:  E B Foa
Journal:  J Clin Psychiatry       Date:  2000       Impact factor: 4.384

2.  Loneliness and health: potential mechanisms.

Authors:  John T Cacioppo; Louise C Hawkley; L Elizabeth Crawford; John M Ernst; Mary H Burleson; Ray B Kowalewski; William B Malarkey; Eve Van Cauter; Gary G Berntson
Journal:  Psychosom Med       Date:  2002 May-Jun       Impact factor: 4.312

3.  Effects of cocaine on heart rate variability in healthy subjects.

Authors:  Wanpen Vongpatanasin; J Andrew Taylor; Ronald G Victor
Journal:  Am J Cardiol       Date:  2004-02-01       Impact factor: 2.778

Review 4.  The Polyvagal Theory: phylogenetic contributions to social behavior.

Authors:  Stephen W Porges
Journal:  Physiol Behav       Date:  2003-08

5.  Longitudinal evidence for unfavorable effects of antidepressants on heart rate variability.

Authors:  Carmilla M M Licht; Eco J C de Geus; Richard van Dyck; Brenda W J H Penninx
Journal:  Biol Psychiatry       Date:  2010-09-16       Impact factor: 13.382

6.  How could MDMA (ecstasy) help anxiety disorders? A neurobiological rationale.

Authors:  P Ø Johansen; T S Krebs
Journal:  J Psychopharmacol       Date:  2009-03-09       Impact factor: 4.153

7.  Increased oxytocin concentrations and prosocial feelings in humans after ecstasy (3,4-methylenedioxymethamphetamine) administration.

Authors:  G J H Dumont; F C G J Sweep; R van der Steen; R Hermsen; A R T Donders; D J Touw; J M A van Gerven; J K Buitelaar; R J Verkes
Journal:  Soc Neurosci       Date:  2009       Impact factor: 2.083

Review 8.  Methodological guidelines for impedance cardiography.

Authors:  A Sherwood; M T Allen; J Fahrenberg; R M Kelsey; W R Lovallo; L J van Doornen
Journal:  Psychophysiology       Date:  1990-01       Impact factor: 4.016

9.  Is ecstasy an "empathogen"? Effects of ±3,4-methylenedioxymethamphetamine on prosocial feelings and identification of emotional states in others.

Authors:  Gillinder Bedi; David Hyman; Harriet de Wit
Journal:  Biol Psychiatry       Date:  2010-10-14       Impact factor: 13.382

10.  Effect of fluoxetine, pemoline and placebo on heart period and QT variability in normal humans.

Authors:  Robert Pohl; Richard Balon; Anusha Jayaraman; Ronald G Doll; Vikram Yeragani
Journal:  J Psychosom Res       Date:  2003-09       Impact factor: 3.006

View more
  4 in total

Review 1.  MDMA for the treatment of mood disorder: all talk no substance?

Authors:  Rachel Patel; Daniel Titheradge
Journal:  Ther Adv Psychopharmacol       Date:  2015-06

Review 2.  Progress and promise for the MDMA drug development program.

Authors:  Allison A Feduccia; Julie Holland; Michael C Mithoefer
Journal:  Psychopharmacology (Berl)       Date:  2017-11-20       Impact factor: 4.530

3.  A Systematic Review of the MDMA Model to Address Social Impairment in Autism.

Authors:  Devahuti Chaliha; John C Mamo; Matthew Albrecht; Virginie Lam; Ryu Takechi; Mauro Vaccarezza
Journal:  Curr Neuropharmacol       Date:  2021       Impact factor: 7.363

4.  Additive Effects of 3,4-Methylenedioxymethamphetamine (MDMA) and Compassionate Imagery on Self-Compassion in Recreational Users of Ecstasy.

Authors:  Sunjeev K Kamboj; Ylva S E Walldén; Caroline J Falconer; Majdah Raji Alotaibi; Ian S Blagbrough; Stephen M Husbands; Tom P Freeman
Journal:  Mindfulness (N Y)       Date:  2017-11-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.